ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,676, issued on Nov. 11, was assigned to Fresenius Medical Care Holdings Inc. (Waltham, Mass.).
"Determining a modality of an extracorporeal blood circuit" was invented by Matthew J. Doyle (Concord, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to medical fluid pumping systems and related devices and methods. In some aspects, a blood treatment system includes a user interface; a processor in communication with the user interface and configured to perform operations including: presenting instructions on the user interface, the instructions pertaining to at least one modality of a set of modalities, wherein the set of mo...